SGI
STJ

Summit Global Investments’s St Jude Medical STJ Stock Holding History

Summit Global Investments’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,500
Closed -$200K – 246
2016
Q4 		$200K Buy
+2,500
New +$198K 0.07% 206

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Summit Global Investments's STJ Position: Q1 2017 in Review

Summit Global Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,500 shares — an estimated $200K sold.

Summit Global Investments first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $200K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Summit Global Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Summit Global Investments sold 2,500 St Jude Medical shares in Q1 2017, an estimated $200K.
  • Summit Global Investments first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • Summit Global Investments's St Jude Medical position peaked at $200K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Summit Global Investments's 13F filing for Q1 2017, filed 17 May 2017.